Having trouble accessing articles? Reset your cache.

July 11 P&P Quick Takes: China keeps cell therapies on 'negative list'; plus PBM rebate disclosures and more

Cell therapies still on China’s 'negative list' for foreign investments
The Chinese government updated its list of sectors in which foreign investors are prohibited from majority or sole ownership of entities, but did not remove restrictions on investments in development and application of human stem cells and genetic

Read the full 470 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers